BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 23174159)

  • 1. Immunoreactivity characterisation of the three structural regions of the human coronavirus OC43 nucleocapsid protein by Western blot: implications for the diagnosis of coronavirus infection.
    Liang FY; Lin LC; Ying TH; Yao CW; Tang TK; Chen YW; Hou MH
    J Virol Methods; 2013 Feb; 187(2):413-20. PubMed ID: 23174159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Baculovirus expression of HCoV-OC43 nucleocapsid protein and development of a Western blot assay for detection of human antibodies against HCoV-OC43.
    Mourez T; Vabret A; Han Y; Dina J; Legrand L; Corbet S; Freymuth F
    J Virol Methods; 2007 Feb; 139(2):175-80. PubMed ID: 17079026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of specific antibodies against SARS-coronavirus nucleocapsid protein without cross reactivity with human coronaviruses 229E and OC43.
    Lee HK; Lee BH; Seok SH; Baek MW; Lee HY; Kim DJ; Na YR; Noh KJ; Park SH; Kumar DN; Kariwa H; Nakauchi M; Heo SJ; Park JH
    J Vet Sci; 2010 Jun; 11(2):165-7. PubMed ID: 20458159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. False-positive results in a recombinant severe acute respiratory syndrome-associated coronavirus (SARS-CoV) nucleocapsid enzyme-linked immunosorbent assay due to HCoV-OC43 and HCoV-229E rectified by Western blotting with recombinant SARS-CoV spike polypeptide.
    Woo PC; Lau SK; Wong BH; Chan KH; Hui WT; Kwan GS; Peiris JS; Couch RB; Yuen KY
    J Clin Microbiol; 2004 Dec; 42(12):5885-8. PubMed ID: 15583332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a recombinant truncated nucleocapsid protein based immunoassay for detection of antibodies against human coronavirus OC43.
    Blanchard EG; Miao C; Haupt TE; Anderson LJ; Haynes LM
    J Virol Methods; 2011 Oct; 177(1):100-6. PubMed ID: 21801752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elucidation of the stability and functional regions of the human coronavirus OC43 nucleocapsid protein.
    Huang CY; Hsu YL; Chiang WL; Hou MH
    Protein Sci; 2009 Nov; 18(11):2209-18. PubMed ID: 19691129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-reactive antibody against human coronavirus OC43 spike protein correlates with disease severity in COVID-19 patients: a retrospective study.
    Guo L; Wang Y; Kang L; Hu Y; Wang L; Zhong J; Chen H; Ren L; Gu X; Wang G; Wang C; Dong X; Wu C; Han L; Wang Y; Fan G; Zou X; Li H; Xu J; Jin Q; Cao B; Wang J
    Emerg Microbes Infect; 2021 Dec; 10(1):664-676. PubMed ID: 33734013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diverse Humoral Immune Responses in Younger and Older Adult COVID-19 Patients.
    Sasson JM; Campo JJ; Carpenter RM; Young MK; Randall AZ; Trappl-Kimmons K; Oberai A; Hung C; Edgar J; Teng AA; Pablo JV; Liang X; Yee A; Petri WA; Camerini D
    mBio; 2021 Jun; 12(3):e0122921. PubMed ID: 34182775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic variability of human coronavirus OC43-, 229E-, and NL63-like strains and their association with lower respiratory tract infections of hospitalized infants and immunocompromised patients.
    Gerna G; Campanini G; Rovida F; Percivalle E; Sarasini A; Marchi A; Baldanti F
    J Med Virol; 2006 Jul; 78(7):938-49. PubMed ID: 16721849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting the Interaction Between Spike Protein and Nucleocapsid Protein for Suppression and Detection of Human Coronavirus OC43.
    Kim J; Kim M; Kim D; Park S; Kang M; Baek K; Choi JK; Maharjan S; Akauliya M; Lee Y; Kwon HJ
    Front Immunol; 2022; 13():835333. PubMed ID: 35359936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Molecular epidemiological study of human coronavirus OC43 in Shanghai from 2009-2016].
    Yang YJ; Hu YW
    Zhonghua Yu Fang Yi Xue Za Zhi; 2018 Jan; 52(1):55-61. PubMed ID: 29334709
    [No Abstract]   [Full Text] [Related]  

  • 12. [Expression and purification of different segments from HCoV-NL63 nucleocapsid protein and their application in detection of antibodies].
    Zhao M; Zhang TY; Zhou WM; Zhao GX; Zhang LL; Gao JM; Tan WJ
    Bing Du Xue Bao; 2011 May; 27(3):244-9. PubMed ID: 21774250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two-way antigenic cross-reactivity between severe acute respiratory syndrome coronavirus (SARS-CoV) and group 1 animal CoVs is mediated through an antigenic site in the N-terminal region of the SARS-CoV nucleoprotein.
    Vlasova AN; Zhang X; Hasoksuz M; Nagesha HS; Haynes LM; Fang Y; Lu S; Saif LJ
    J Virol; 2007 Dec; 81(24):13365-77. PubMed ID: 17913799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antigenicity analysis of nucleocapsid proteins of 3 human coronaviruses SARS-CoV, 229E and OC43 with their monoclonal antibodies].
    Qiu LW; Wang YD; Liao ZY; Wen K; Che XY
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Mar; 26(3):290-3. PubMed ID: 16546729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The dominance of human coronavirus OC43 and NL63 infections in infants.
    Dijkman R; Jebbink MF; Gaunt E; Rossen JW; Templeton KE; Kuijpers TW; van der Hoek L
    J Clin Virol; 2012 Feb; 53(2):135-9. PubMed ID: 22188723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigenic cross-reactivity between severe acute respiratory syndrome-associated coronavirus and human coronaviruses 229E and OC43.
    Che XY; Qiu LW; Liao ZY; Wang YD; Wen K; Pan YX; Hao W; Mei YB; Cheng VC; Yuen KY
    J Infect Dis; 2005 Jun; 191(12):2033-7. PubMed ID: 15897988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two serological approaches for detection of antibodies to SARS-CoV-2 in different scenarios: a screening tool and a point-of-care test.
    Hoste ACR; Venteo A; Fresco-Taboada A; Tapia I; Monedero A; López L; Jebbink MF; Pérez-Ramírez E; Jimenez-Clavero MA; Almonacid M; Muñoz P; Guinea J; Vela C; van der Hoek L; Rueda P; Sastre P
    Diagn Microbiol Infect Dis; 2020 Dec; 98(4):115167. PubMed ID: 32890908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seroprevalence and SARS-CoV-2 cross-reactivity of endemic coronavirus OC43 and 229E antibodies in Finnish children and adults.
    Tamminen K; Salminen M; Blazevic V
    Clin Immunol; 2021 Aug; 229():108782. PubMed ID: 34118402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genotype shift in human coronavirus OC43 and emergence of a novel genotype by natural recombination.
    Zhang Y; Li J; Xiao Y; Zhang J; Wang Y; Chen L; Paranhos-Baccalà G; Ren L; Wang J
    J Infect; 2015 Jun; 70(6):641-50. PubMed ID: 25530469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular epidemiology and evolutionary histories of human coronavirus OC43 and HKU1 among patients with upper respiratory tract infections in Kuala Lumpur, Malaysia.
    Al-Khannaq MN; Ng KT; Oong XY; Pang YK; Takebe Y; Chook JB; Hanafi NS; Kamarulzaman A; Tee KK
    Virol J; 2016 Feb; 13():33. PubMed ID: 26916286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.